Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Nd:YAG laser can reduce hair with multiple treatments, but permanent removal isn't guaranteed.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Cetuximab can cause eyelash growth, which is rare but manageable.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The study found no common cause for a girl's crystalline cataract and uncombable hair, suggesting their co-occurrence might be coincidental.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.